Bone defect healing with an osteogenic protein-1 device combined with carboxymethylcellulose

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 75, Issue 1, 2005, Pages 137-145

  Cook, Stephen D ^a   Salkeld, Samantha L ^a   Patron, Laura P ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Bone graft; Carrier; Matrix; Osteogenic protein

Indexed keywords

BONE; CELLULOSE; DOSIMETRY; HISTOLOGY; RADIOGRAPHY;

ANIMAL MODEL; BONE GRAFT; CARRIER; OSTEOGENIC PROTEIN;

COLLAGEN;

CARBOXYMETHYLCELLULOSE; COLLAGEN; RECOMBINANT OSTEOGENIC PROTEIN 1;

ADOLESCENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DEFECT; BONE RADIOGRAPHY; BONE STRENGTH; COMPARATIVE STUDY; DEVICE; DOG; DOSE RESPONSE; DRUG DELIVERY SYSTEM; FRACTURE HEALING; HISTOLOGY; MALE; MATERIALS HANDLING; NONHUMAN; OSSIFICATION; ULNA; WOUND HEALING;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CARBOXYMETHYLCELLULOSE; DOGS; FRACTURE HEALING; FRACTURES, BONE; HUMANS; MALE; MATERIALS TESTING; TRANSFORMING GROWTH FACTOR BETA;

CELLULOSE; COLLAGEN; HISTOLOGY; RADIOGRAPHY;

EID: 25844447734     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30271     Document Type: Article

References (31)

1. Urist MR. Bone: Formation by induction. Science 1965;150: 893-899.
2. Sampath TK, Muthukumaran N, Reddi AH. Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci USA 1987;84:7109-7113.
3. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242: 1528-1534.
4. Luyten FP, Cunningham NS, Ma S, Muthukumaran N, Hammonds RG, Nevins WB, Woods WI, Reddi AH. Purification and partial amino acid sequence of osteogenin, protein initiating bone differentiation. J Biol Chem 1989;264:13377-13380.
5. Sampath TK, Reddi AH. Homology of bone-inductive proteins from human, monkey, bovine, and rat extracellular matrix. Proc Natl Acad Sci USA 1983;80:6591-6595.
6. Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science 1983;220:680-686.
7. Sampath TK, Nathanson MA, Reddi AH. In vitro transformation of mesenchymal cells derived from embryonic muscle into cartilage in response to extracellular matrix components of bone. Proc Natl Acad Sci USA 1984;81:3419-3423.
8. Nakagawa M, Urist MR. Chondrogenesis in tissue cultures of muscle under the influence of a diffusible component of bone matrix. Proc Soc Exp Biol Med 1977;154:568-572.
9. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC. Recombinant human bone morphogenetic protein-7 induces healing in canine long-bone segmental defect model. Clin Orthop 1994;301:302-312.
10. Cook SD, Baffes GC, Wolfe MW, Sampath TK, Rueger DC, Whitecloud TS. The effect of recombinant human osteogenic protein-1 (rhOP-1) on the healing of large segmental bone defects. J Bone Joint Surg Am 1994;76-A:827-838.
11. Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 1995; 77-A:734-750.
12. Urist MR, Huo YK, Brownell AG, Hohl WM, Buyske J, Lietze A, Tempst P, Hunkapiller M, DeLange RJ. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci USA 1984;81:371-337.
13. Nakahara H, Takaoka K, Koezuka M, Sugamoto K, Tsuda T, Ono K. Periosteal bone formation elicited by partially purified bone morphogenetic protein. Clin Orthop 1989;239:299-305.
14. Pinholt EM, Solheim E, Bang G, Sudmann E. Bone induction by composite of bioerodible polyorthoester and demineralized bone matrix in rats. Acta Orthop Scand 1991;62:476-480.
15. Cook SD, Dalton JE, Tan EH, Whitecloud TS, Rueger DC. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 1994;19:1655-1663.
16. Cook SD. Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites. Orthopedics 1999;22:669-671.
17. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 2001;83-A(Suppl 1):S151-S158.
18. Stelzer GI, Klug ED. Carboxymethylcellulose. In: Davidson RL, editor. Handbook of water-soluble gums and resins. New York: McGraw-Hill; 1980.
19. Rodgers JB, Vasconez HC, Wells MD, DeLuca PP, Faugere MC, Fink BF, Hamilton D. Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects. J Craniofac Surg 1998;9:147-153.
20. Aspenberg P, Lohmander LS. Fibroblast growth factor stimulates bone formation. Bone induction studied in rats. Acta Orthop Scand 1989;60:473-476.
21. Animal Welfare Act: United States Code, Title 7. 1966; Sections 2131-2156.
22. Cook SD, Salkeld SL, Brinker MR, Wolfe MW, Rueger DC. Use of an osteoinductive biomaterial (rhOP-1) in healing large segmental bone defects. J Orthop Trauma 1998;12:407-412.
23. Horowitz MC, Friedlaender GE. The immune response to bone grafts. In: Friedlaender GE, Goldberg VM, editors. Bone and cartilage allografts. Park Ridge: American Academy of Orthopaedics Surgeons; 1991. p 85-102.
24. Damien CJ, Parsons JR. Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater 1991;2:187-208.
25. Key JA. The effect of a local calcium depot on osteogenesis and healing fractures. J Bone Joint Surg 1934;16:176-184.
26. Delloye C, Verhelpen M, d'Hemricourt J, Govaerts B, Bourgois R. Morphometric and physical investigations of segmental cortical bone autografts and allografts in canine ulnar defects. Clin Orthop 1992;282:273-292.
27. Heckman JD, Boyan BD, Aufdemorte TB, Abbott JT. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg Am 1991;73-A:750-764.
28. Heiple KG, Chase SW, Herndon CH. A comparative study of the healing process following different types of bone transplantation. J Bone Joint Surg Am 1963;45-A:1593-1616.
29. Duggirala SS, Rodgers JB, DeLuca PP. The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2. Pharm Dev Technol 1996;1:165-174.
30. Santa-Comba A, Pereira A, Lemos R, Santos D, Amarante J, Pinto M, Tavares P, Bahia F. Evaluation of carboxymethylcellulose, hydroxypropylmethylcellulose, and aluminium hydroxide as potential carriers for rhBMP-2. J Biomed Mater Res 2001;55:396-400.
31. Salkeld SL, Patron LP, Barrack RL, Cook SD. The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am 2001;83-A:803-816.